BioLargo
Answers
Administration's Urgent Call
for Mitigation of PFAS Forever Chemicals
Highlights:
-
Federal
enforcement of PFAS (per- and polyfluoroalkyl
substances) in drinking water
regulations
is imminent
-
The
water
treatment sector is desperate for
effective, economical solutions to
remove PFAS from drinking water
-
BioLargo
(OTCQB:BLGO)
is rolling
out its BioLargo AEC PFAS water
treatment technology, which takes a novel and economical
approach
to removing these
chemicals from water
-
The
BioLargo
solution
produces
far
less
PFAS-laden
waste than
traditional carbon-based
technologies, leading to cost savings
and a dramatically reduced
carbon footprint
-
BioLargo's
PFAS
solution will serve a
multi-billion-dollar
market
while also
aligning with the new administration's focus on environmental
issues such as water
contamination
February 24, 2021
-- InvestorsHub NewsWire -- via BioLargo, Inc.
-- The
Biden administration has wasted no time enacting new environmental
policies since taking office last month.
Our company,
BioLargo (OTCQB:BLGO),
is stepping up with exciting new
technologies to take advantage
of
the
opportunities created by President
Biden's far-reaching
environmental
agenda.
One of
the new
administration's first moves was
to announce
final regulatory determinations on the safe levels of
the
widespread and
toxic water contaminants called per- and polyfluoroalkyl
substances (PFAS) in drinking
water.
This means the Federal
Government has decided
to create a
national standard for what concentration of these
chemicals will meet the threshold for regulatory action
when found in
drinking water supplies, and will now start the process of
regulating the chemicals through the Safe Drinking Water
Act.
The
administration also gave advance notice that they may designate
PFAS as federally regulated
hazardous
substances and/or regulated hazardous waste.
These actions set off a long-anticipated race
for municipalities around the country to identify and adopt water
treatment systems that effectively and affordably remove the
hard-to-treat chemicals from drinking water.
PFAS are a group
of man-made chemicals found in countless household items
like electronics, cleaning supplies, non-stick cookware and
more.
While many of
these items are not known to be dangerous by virtue of containing
PFAS, their ubiquitous
manufacturing throughout the latter half of
the 20th
century led to
widespread contamination of lakes, rivers, wells and groundwater throughout
the U.S. In recent decades,
there has been
mounting evidence of the damage to human health
caused by these chemicals,
including cancer and hormone disorders.
Todd
Haynes's 2019 film
Dark Waters told the story of how lawyer
Robert Bilott (played by Mark
Ruffalo) pursued DuPont in the
late 1990s for contaminating
Midwest
communities with
then-unregulated PFAS chemicals. While the issue of
PFAS
water
contamination
was well-documented by scientists
at the
time of the movie's
release, Dark
Waters helped thrust the issue into
the public eye.
In some areas
such as Southern California, municipalities are already
actively installing PFAS treatment systems, and
as federal regulations go into effect, the adoption of PFAS
treatment systems is expected to expand dramatically across
the country. Drinking water
utilities have struggled to find
economical
treatment
technologies that can efficiently
remove PFAS from
water without stretching
their
budgets and generating mountains
of toxic waste as a by-product of
treatment. In Orange County,
11
water districts have launched a lawsuit against major PFAS
polluters, including DuPont and
3M,
to
seek
compensation for mandated well closures
and water treatment system retrofitting needed to remove PFAS from
their drinking water supplies.
At
present,
carbon
filtration is the most common PFAS removal
technology, but it comes with a serious
downside – it generates huge volumes of PFAS-laden carbon waste
that requires
disposal. Usually,
municipalities have to foot the bill for the costly
transport and disposal of that PFAS-laden waste, which is
normally
done by
incineration. Not only is PFAS carbon
incineration costly, but
a growing body of evidence suggests that it generates toxic volatile
air contaminants (in addition to greenhouse gases) as a result of
incomplete combustion of the PFAS chemicals. Disposal of
PFAS-laden waste
therefore remains a contentious issue (one that regulators are
starting to look at) and municipalities would be
wise to consider technologies that produce less PFAS-laden
waste.
Our
company,
BioLargo, an environmental
technologies innovator (OTCQB:BLGO),
has invented and
is pilot-testing an innovative technology
that removes PFAS chemicals from
water faster and
more
cheaply than carbon
filtration. Our technology, called
the
BioLargo AEC, uses electrolysis to
extract
PFAS
molecules
from water and
deposit them onto proprietary
membranes
while
using
little
electricity and no input chemistry. Proven to be more than 99.9%
effective in removing PFAS from contaminated
water, it produces only a fraction of
the PFAS-laden waste that carbon filtration treatment
creates, resulting in
substantially
lower waste disposal
costs and better
environmental outcomes.
How big is the market to solve
this PFAS problem?
Experts have
estimated that over the next decade,
municipalities in
the United States alone will spend
billions of dollars
a
year on PFAS treatment
systems. We at BioLargo aim to
address this
rapidly growing market by targeting
municipalities interested
in
lower operating costs,
decreased
carbon
footprints, increased constituent
well-being
and
diminished
regulatory risks
associated with PFAS waste disposal.
The BioLargo AEC
is rolling out in pilots and commercial trials at municipalities in
Southern California and the Midwest over the next year
as more public
officials and advocacy groups ratchet up
the pressure to
clean up the country's PFAS contamination
mess.
We at
BioLargo
are focused on
creating a positive impact around the
world with our innovative
clean water,
clean air and infection
control
solutions.
Our company
presents a
scalable business model that targets high-impact
CleanTech
market
opportunities like PFAS treatment while
staying true to our mission statement to "make life
better."
About
BioLargo, Inc.
BioLargo, Inc.
(OTCQB:BLGO)
invents, develops, and commercializes innovative platform
technologies to solve challenging environmental problems like PFAS
contamination, advanced water and wastewater treatment, industrial
odor and VOC control, air quality control, and infection control.
With over 13 years of extensive R&D, BLGO holds a wide array of
issued patents, maintains a robust pipeline of products, and
provides full-service environmental engineering. Our peer-reviewed
scientific approach allows us to invent or acquire novel
technologies and develop them to maturity through our operating
subsidiaries. With a keen emphasis on collaborations with academic,
municipal, and commercial organizations and associations, BLGO has
proven itself with over 80 awarded grants and numerous pilot
projects. We monetize through direct sales, recurring service
contracts, licensing agreements, strategic joint venture formation
and/or the sale of the IP. Several of our technologies are
commercially available and are advancing as disrupters in their
respective markets. See our website at
www.BioLargo.com.
Contact
Information
Dennis P.
Calvert
President and
CEO, BioLargo, Inc.
888-400-2863
Safe Harbor
Act – caution regarding forward looking statements
This press
release contains forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995. These
forward-looking statements include without limitation those
about BioLargo's
(the "Company")
expectations regarding the impact of the COVID-19 pandemic;
anticipated revenue; and plans for future operations. These
statements involve risks and uncertainties, and actual results may
differ materially from any future results expressed or implied by
the forward-looking statements. Risks and uncertainties include
without limitation: the effect of the COVID-19 pandemic on the
Company's business, results of operations, financial condition, and
stock price; the effect of regional economic conditions on the
Company's business, including effects on purchasing decisions by
consumers and businesses; the ability of the Company to compete in
markets that are highly competitive and subject to rapid
technological change; the ability of the Company to manage frequent
introductions and transitions of products and services, including
delivering to the marketplace, and stimulating customer demand for,
new products, services, and technological innovations on a
timely basis; the dependency of the
Company on the performance of distributors of the Company's
products. More information on these risks and other potential
factors that could affect the Company's business and financial
results is included in the Company's filings with the SEC,
including in the "Risk Factors" and "Management's Discussion and
Analysis of Financial Condition and Results of Operations" sections
of the Company's most recently filed periodic reports on Form 10-K
and Form 10-Q and subsequent filings. The Company assumes no
obligation to update any forward-looking statements or information,
which speak as of their respective dates.
SOURCE: Written
by: BioLargo, Inc.
BioLargo (QX) (USOTC:BLGO)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
BioLargo (QX) (USOTC:BLGO)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025
